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Essentials
• C57BL/6J-tissue plasminogen activator (tPA)-deficient
mice are widely used to study tPA function.
• Congenic C57BL/6J-tPA-deficient mice harbor large
129-derived chromosomal segments.
• The 129-derived chromosomal segments contain gene
mutations that may confound data interpretation.
• Passenger mutation-free isogenic tPA-deficient mice
were generated for study of tPA function.
Summary. Background: The ability to generate defined
null mutations in mice revolutionized the analysis of gene
function in mammals. However, gene-deficient mice gen-
erated by using 129-derived embryonic stem cells may
carry large segments of 129 DNA, even when extensively
backcrossed to reference strains, such as C57BL/6J, and
this may confound interpretation of experiments per-
formed in these mice. Tissue plasminogen activator (tPA),
encoded by the PLAT gene, is a fibrinolytic serine pro-
tease that is widely expressed in the brain. A number of
neurological abnormalities have been reported in tPA-defi-
cient mice. Objectives: To study genetic contamination of
tPA-deficient mice. Materials and methods: Whole genome
expression array analysis, RNAseq expression profiling,
low- and high-density single nucleotide polymorphism
(SNP) analysis, bioinformatics and genome editing were
used to analyze gene expression in tPA-deficient mouse
brains. Results and conclusions: Genes differentially
expressed in the brain of Plat/ mice from two indepen-
dent colonies highly backcrossed onto the C57BL/6J strain
clustered near Plat on chromosome 8. SNP analysis attrib-
uted this anomaly to about 20 Mbp of DNA flanking Plat
being of 129 origin in both strains. Bioinformatic analysis
of these 129-derived chromosomal segments identified a
significant number of mutations in genes co-segregating
with the targeted Plat allele, including several potential null
mutations. Using zinc finger nuclease technology, we gener-
ated novel ‘passenger mutation’-free isogenic C57BL/6J-
Plat/ and FVB/NJ-Plat/ mouse strains by introducing
an 11 bp deletion into the exon encoding the signal peptide.
These novel mouse strains will be a useful community
resource for further exploration of tPA function in physio-
logical and pathological processes.
Keywords: brain; congenic mice; gene targeting; mutation;
tissue plasminogen activator.
Introduction
The development of methods to selectively disrupt genes in
mice by homologous recombination in embryonic stem
(ES) cells provided a potent new tool for analysis of gene
function in mammals that has been of immeasurable value
to a wide range of research fields [1]. Because germ line-
competent ES cells were most successfully derived from
various sub-strains of the 129 mouse strain, the large
majority of gene disruptions initially were made in this
strain. Due to the poor breeding characteristics, neurologi-
cal and neuroanatomical abnormalities and high tumor
incidence of 129 mice, gene-targeted mice developed using
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129 ES cells typically were backcrossed to inbred reference
strains, such as C57BL/6J. However, because of the low
probability of meiotic crossover occurring close to the tar-
geted gene, a large region of DNA is likely to remain of 129
origin, even in ‘congenic’ mice backcrossed for 10 genera-
tions (P = 0.91 for more than 1 centiMorgan of 129-
derived DNA flanking each side of the targeted gene) [2].
Importantly in this respect, a recent direct comparison of
the 129 and C57BL/6J genome sequences uncovered that
the two strains differ by no less than 1395 deletions, inser-
tions or nucleotide substitutions in protein coding regions,
which resulted in 188 lost or gained stop codons, 875 frame
shift variants and 332 splice donor or acceptor variants [2].
This finding led the authors of the above study to conclude
that essentially all constitutively gene-targeted mouse
strains generated using 129-derived ES cells carry ‘passen-
ger mutations’ that confound data interpretation [2].
Indeed, several examples of erroneous attribution of
observed phenotypes in gene-targeted mice generated using
129-derived ES cells have emerged recently [2–4]. With
regards to extracellular proteases, the reported resistance
of matrix metalloproteinase (MMP)-13-deficient mice and,
most likely, MMP-7-deficient and MMP-8-deficient mice,
to LPS-induced lethality was demonstrated not to be a con-
sequence of the loss of the MMP. Rather, it was caused by
a null mutation in the neighboring Casp11 gene, which is
present in 129 mice, but not in C57BL/6J mice [2]. A sec-
ond issue with many ES cell-generated gene-disrupted mice
relates to the use of homologous recombination to generate
the null mutation. This strategy often involves the deletion
of large segments of DNA within the targeted gene that
could result in the deletion of cis-acting regulatory elements
and microRNAs, while the insertion of a powerful neomy-
cin selection cassette could similarly modulate the expres-
sion of genes flanking the targeted locus.
Tissue plasminogen activator (tPA) is a fibrinolytic ser-
ine protease [5] that is widely expressed in the brain
[6–10], where it is involved in a diverse array of physio-
logical and pathophysiological processes unrelated to fib-
rinolysis that were identified in large part through the
analysis of tPA-deficient mice [11–25].
During transcriptomic profiling of genes differentially
expressed in the brains of tPA-deficient mice extensively
backcrossed to the C57BL/6J strain, we noted a highly
significant over-representation of differentially expressed
genes clustering around the Plat gene, encoding tPA, on
chromosome 8. A similar anomalous clustering of differ-
entially expressed genes was observed when we analyzed
a second colony of tPA-deficient mice independently
highly backcrossed to the C57BL/6J strain. Single nucleo-
tide polymorphism (SNP) analysis provided evidence that
at least 22 Mbp of DNA flanking Plat remained of 129
origin in each C57BL/6J- Plat/ strain. Furthermore,
bioinformatic analysis identified several mutations, includ-
ing potential null mutations, in protein coding genes
located on this chromosomal segment.
Using zinc finger nuclease (Zfn) technology, we engi-
neered a null mutation in the Plat gene of C57BL/6J and
FVB/N mice. We demonstrate that isogenic C57BL/6J-
Plat/ mice, free of 129 DNA, do not show anomalous
clustering of differentially expressed genes in proximity to
the targeted Plat gene. These novel isogenic Plat/
mouse strains constitute a valuable community resource




Mice were housed in standard barrier facilities under
approved protocols.
Expression array analysis
Twelve- to 14-week-old male ‘Melbourne’ C57BL/6J-
Plat/ and age-matched C57BL/6J mice (Jackson Labo-
ratory, Bar Harbor, ME, USA) were transcardially trans-
fused with ice-cold PBS (eight per genotype). The
hippocampus was dissected out and placed in ‘RNA
later’. RNA was extracted using the ‘RNeasy Lipid Tis-
sue’ kit (Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions. RNA was then pooled from
pairs of mice to give four samples from each genotype for
subsequent analysis. The extracted RNA was quality con-
trolled, hybridized to Illumina microarray chips and ana-
lyzed by the SRC MicroRNA facility (University of
Queensland, Australia) using MouseWG-6 v2.0 Expres-
sion BeadChip (Catalog ID: BD-201-0202). Genes were
considered differentially expressed if the adjusted P value
was less than 0.05. The original high-throughput microar-





Six-week-old ‘Michigan’ C57BL/6J-Plat/ and
‘Bethesda’ C57BL/6J-Plat/ littermates (four mice per
genotype), and age-matched wild-type C57BL/6J control
mice (four mice per genotype), were euthanized by CO2
inhalation. The brains were dissected out, the olfactory
bulb and cerebellum removed, and the brains snap fro-
zen in liquid nitrogen. cDNA library preparation and
Illumina high-throughput sequencing were performed by
The University of Michigan’s DNA Sequencing Core.
Bioinformatic analysis of these data was conducted by
the University of Michigan Bioinformatics Core. All
data from these studies have been deposited in the gene
expression omnibus (GEO) database with accession
number GSE76093. Genes were considered differentially
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expressed if presenting with an adjusted P value
(q-value) of 0.05001 or less and fold-difference in expres-
sion of more than 0.3. Genes located on the Y chromo-
some were excluded from the analysis because the
analyzed mice were both male and female.
SNP analysis
Low-density SNP analysis of the entire mouse genome was
performed by the Jackson Laboratory using the ‘JAX 150
SNP Panel’ polymorphic between C57BL/6J and 129
(Table S1). The panel consists of 154 SNPs that cover the
19 autosomes and the X chromosome with a density of
~15–20 Mbp/SNP. High-density SNP analysis of mouse
chromosome 8 was performed by the Jackson Laboratory
using a chromosome 8-specific panel of 34 SNPs, polymor-
phic between C57BL/6J and 129, covering the length of the
chromosome with a density of ~3.5 Mbp/SNP (Table S2).
Generation of Plat/ mice using Zfns
A pair of Zinc finger-FokI fragment fusion proteins (Zfns)
binding, respectively, 50-GACTGGCTTTCCCAT-30 (nu-
cleotides 9399–9413 of the Plat gene, NC_000074.6) and 50-
GACCAGGTGGGT’30 (nucleotides 9419–9430 of the Plat
gene) were generated by Sigma-Aldrich (St Louis, MO,
USA). mRNA encoding the Zfn pair was generated by
in vitro transcription and microinjected into the male pronu-
cleus of C57BL/6J and FVB/NJ zygotes, which were
implanted into pseudo-pregnant mice. The ensuing founders
were screened by PCR using the primer pair 50-AAGAGT-
CATTGCTGGATGGG-30 (forward) and 50-GAT-
CACTCCTGGGAACGTGT-30 (reverse), which amplifies
the 325 bp fragment constituting nucleotides 9221–9545 of
the Plat gene. Founders positive for mutations in the signal
peptide-encoding exon 2 of Plat were further characterized
byDNA sequencing and screened for germ line transmission
by breeding to C57BL/6J or FVB/NJ.
tPA Western blot analysis
Non-reduced and non-boiled protein lysates from brains
were separated by SDS-PAGE and transferred to poly
(vinylidene difluoride) (PVDF) membranes. The mem-
branes were blocked with 5% non-fat dry milk for 1 h.
The blot was incubated with 2 lg/mL rabbit anti-human
tPA (ASHTPA-GF; Molecular Innovation, Novi, MI,
USA) for 1 h at room temperature. Bound antibody was
visualized by incubation for 1 h with donkey anti-rabbit-
HRP (Jackson Immuno Research, 711-036-152) 1 : 5000.
Plasminogen-casein zymography
Plasminogen-casein zymography was performed as previ-
ously described [26]. Lysis zones were visualized by stain-
ing of gels with Coomassie brilliant blue.
tPA activity assay
Active tPA was determined using a commercial sandwich
tPA capture ELISA kit (Molecular Innovations,
NTBIOCPAI) as recommended by the manufacturer.
Statistical analysis
Distribution of differentially expressed genes over all
chromosomes: we used a chi-square statistic with a refer-
ence distribution calculated using simulation (because
many of the expected hit counts are very small). Specifi-
cally, the expected number of ‘hits’ per chromosome,
assuming uniform distribution, was calculated and com-
pared with the observed number of hits per chromosome.
This comparison utilized a chi-square statistic (but not a
chi-square reference distribution). To obtain a reference
distribution we generated Poisson counts from 100 000
randomizations with mean values equal to the expected
number of hits per chromosome under uniformity,
accounting for the differing lengths of the chromosomes.
Positions of differentially expressed genes on chromo-
some 8: to assess the probability of the observed hits on
chromosome 8 being random, we divided the chromo-
some into 1 Mbp intervals and counted the number of
hits per interval. We then used a chi-square statistic to
compare this distribution of hit positions with what
would be expected under a uniform distribution in which
the hits were equally likely to occur at any point along
chromosome 8. The reference distribution was calculated
using simulation, with a uniform distribution to define
random positions for hits along the length of chromo-
some 8.
Bioinformatic analysis
Bioinformatic analysis of ‘passenger mutations’ co-segre-
gating with the targeted Plat allele was carried out using
the Sanger ‘Mouse Genomes Project – Query SNPs,
indels or SVs’ website (http://www.sanger.ac.uk/sanger/
Mouse_SnpViewer/rel-1505) [27,28].
Results
Transcriptomic profiling of brains of two independently
generated strains of congenic C57BL/6J-Plat/ mice reveals
anomalous clustering of differentially expressed genes
around Plat on chromosome 8
C57BL/6J-Plattm1Mlg mice [29] were housed at the Aus-
tralian Centre for Blood Diseases, Monash University
(hereafter termed Melbourne C57BL/6J-Plat/ mice). In
2009, when the expression analysis was carried out, these
mice were estimated to be backcrossed to C57BL/6J mice
for 13 generations. RNA was isolated from the brains of
Melbourne C57BL/6J-Plat/ mice and from co-habitating
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age- and sex-matched C57BL/6J mice and hybridized to
whole genome expression arrays. Quadruplicate analysis
was performed, with each sample representing pools of
RNA from two mice. Overall, only 13 genes reporting in
the array were identified as differentially expressed in the
brain of C57BL/6J-Plat/ mice, when compared with the
C57BL/6J control mice (Table 1). Surprisingly, 11 of these
13 genes (85%) were located on chromosome 8, which also
harbors the Plat gene (P < 0.000001, see ‘Materials and
methods’ for details on statistics). Furthermore, all of these
11 genes clustered around the Plat gene, on a chromosomal
segment spanning approximately 19 Mbp upstream to
8 Mbp downstream of Plat (Fig. 1A). This clustering of
differentially expressed genes within this 27 Mbp segment
is also highly anomalous (P < 0.000001), considering that
the total length of mouse chromosome 8 is approximately
129 Mbp and the total length of the mouse genome is more
than 2600 Mbp.
We next set out to examine if the abnormal distribution
of differentially expressed genes in Melbourne C57BL/6J-
Plat/ mice was also observed in other congenic colonies
of tPA-deficient mice. Specifically, we analyzed C57BL/
6J-Plattm1Mlg mice housed at the University of Michigan
(hereafter termed Michigan C57BL/6J-Plat/ mice), esti-
mated to be backcrossed for > 10 generations to C57BL/
6J in 2015 when the analysis was carried out. Brains of
four Michigan C57BL/6J-Plat/ mice and four wild-type
C57BL/6J mice from Jackson Laboratories were subjected
to transcriptomic profiling by RNAseq. We again
observed an abnormally high frequency of differentially
expressed genes (eight of 32, 25%) located on chromo-
some 8 (P < 0.003) (Table 2). Furthermore, all eight
genes were located approximately 18 Mbp upstream to
5 Mbp downstream of Plat (P < 0.000001) (Fig. 1B).
Evidence for 129 origin of differentially expressed genes on
chromosome 8 of tPA-deficient mice
To explore the basis of the anomalous clustering of differ-
entially expressed genes around the Plat gene in the two
independently backcrossed congenic strains of C57BL/6J-
Plat/ mice, we next contracted Jackson Laboratories to
perform SNP analysis of Michigan C57BL/6J-Plat/
mice and Melbourne C57BL/6J-Plat/ mice. We first
employed a JAX 150 SNP Panel polymorphic between
C57BL/6J and 129, which covers the 19 autosomes and
the X chromosome with a density of ~15–20 Mbp. Strik-
ingly, of 154 SNPs analyzed in Michigan C57BL/6J-
Plat/ mice, only one was found to be 129 specific
(rs3701395, Table S1) and this SNP was located
19.7 Mbp upstream of Plat, just upstream of a cluster of
five differentially expressed genes. This SNP was also 129
specific in Melbourne C57BL/6J-Plat/ mice, as was the
adjacent SNP (rs3701395 and rs3684251, Table S1). Mel-
bourne C57BL/6J-Plat/ mice were also heterozygote for
one chromosome 1 SNP (rs3697376, Table S1). Remark-
ably, this SNP was located very close to both the chro-
mosome 1-located genes differentially expressed in
Melbourne C57BL/6J-Plat/ mice (chromosome loca-
tion-bp, rs3697376: 65042402. C430010P07Rik: 66719248-
66817562. Mtap2: 66175273-66442583). Based on these
findings, we next performed a high-density SNP analysis
of chromosome 8, employing 34 SNPs, polymorphic
between C57BL/6J and 129 (Fig. 2A and B and
Table S2). In Michigan C57BL/6J-Plat/ mice, a contin-
uous cluster of seven SNPs analyzed, located 19-0.3 Mbp
upstream of Plat, were identified as being 129 specific
(Fig. 2A). An identical cluster of 129-derived SNPs was
found in Melbourne C57BL/6J-Plat/ mice, which also
displayed two additional 129 SNPs located just down-
stream of Plat (Fig. 2B). Notably, the chromosomal seg-
ments identified in the SNP analysis as being 129 derived
in the two mouse strains harbored most of the genes dif-
ferentially expressed on chromosome 8 of the Michigan
C57BL/6J-Plat/ mice and all of the identified genes dif-
ferentially expressed in the Melbourne C57BL/6J-Plat/
mice (Fig. 2A and B, and Table S1).
Bioinformatic analysis identifies multiple passenger
mutations in congenic C57BL/6J-Plat/ mice
Locating the specific regions of 129-derived DNA in
Michigan C57BL/6J-Plat/ and Melbourne C57BL/6J-
Plat/ mice allowed for the direct bioinformatic identifi-
cation of ‘passenger mutations’ co-segregating with the
targeted Plat allele by using the Sanger ‘Mouse Genomes
Project – Query SNPs, indels or SVs’ website (http://
www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1505)
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[27,28]. Interestingly, the 129-derived regions of both
Michigan C57BL/6J-Plat/ mice and Melbourne C57BL/
6J-Plat/ mice harbored five protein-coding genes
(Cd209a, Cd209b, Ccl25, Defb34 and Defb46) predicted to
be null in 129 mice and wild-type in C57BL/6J mice or vice
versa, as evidenced by the presence of in-frame stop
codons, frame shift-inducing insertions and deletions
(Table 3). An additional eight genes (Arhgef18, Cd209e,
BC068157, Gm560, Tubgcp3, Mcf2 l, Myom2 and Mchp1)
harbored one or more mutations causing non-conservative
amino acid substitutions. Owing to additional 129-derived
regions upstream of Plat, Melbourne C57BL/6J-Plat/
mice also displayed mutations in Adam3.
C57BL/6J-Plat/ mice, generated by zinc finger nuclease
targeting of C57BL/6J mice, do not show anomalous
clustering of differentially expressed genes around Plat
We next used custom-designed zinc finger nucleases (Zfns)
to generate tPA-deficient mice de novo. A Zfn was
engineered to introduce mutations into the signal peptide-
encoding exon 2 of Plat (Fig. 3). mRNA encoding the
Zfn was microinjected into fertilized C57BL/6J and FVB/
NJ embryos that were implanted into pseudo-pregnant
females. Analysis of born offspring identified a number of
mice with mutations in exon 2 of Plat. This included
C57BL/6J and FVB/NJ offspring with an identical 11 bp
deletion in the signal peptide-coding exon 2, which were
selected for further analysis. This deletion removes
nucleotides 52–62 of the Plat open reading frame and
introduces a frame shift mutation after Pro17 of the tPA
signal peptide and a premature stop signal (Fig. 3A). This
gave rise to a null allele, as confirmed by plasminogen-
casein zymography (Fig. 3B), Western blot (Fig. 3C) and
tPA activity assays (Fig. 3D) of brain tissue from mice
bred to homozygosity for the targeted allele and their
wild-type littermates. These novel mouse strains hereafter
are termed, respectively, Bethesda C57BL/6J-Plat/ and
Bethesda FVB/NJ-Plat/. As expected, low-density SNP



























































































































Fig. 1. The clustering of genes differentially expressed in brains of congenic tPA-deficient mice in the vicinity of Plat is unrelated to the loss of
tPA. (A) RNA was extracted from congenic ‘Melbourne’ C57BL/6J-Plat/ mice and age- and gender-matched C57BL/6J wild-type controls,
and whole-genome transcriptome analysis was performed by using expression arrays. The locations of Plat and of differentially expressed genes
on chromosome 8 are shown. Eleven of 13 differentially expressed genes (excluding Plat) in tPA-deficient brains (85%) are located within a 27
Mbp interval, flanking Plat. (B) RNA was extracted from congenic ‘Michigan’ C57BL/6J-Plat/ mice and wild-type littermates and whole-
genome transcriptome analysis was performed by RNAseq. The locations of Plat and of differentially expressed genes on chromosome 8 are
shown. Eight of 32 differentially expressed genes (excluding Plat) in tPA-deficient brains (25%) are located within a 30 Mbp interval flanking
Plat. (C). RNA was extracted from ‘Michigan’ C57BL/6J-Plat/ mice and ‘Bethesda’ C57BL/6J-Plat/ littermates and whole-genome tran-
scriptome analysis was performed by RNAseq. The locations of Plat and of differentially expressed genes on chromosome 8 are shown. Seven
of 19 differentially expressed genes (excluding Plat) (37%) are located within a 26 Mbp interval flanking Plat. (D) No anomalous clustering of
differentially expressed genes in brains of isogenic ‘Bethesda’ C57BL/6J-Plat/ mice around Plat on chromosome 8. RNA was extracted from
‘Bethesda’ C57BL/6J-Plat/ mice and wild-type littermates and whole-genome transcriptome analysis was performed by RNAseq. The loca-
tions of Plat and of differentially expressed genes on chromosome 8 are shown.
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SNPs to be C57BL/6J derived (Table S1). High-density
SNP analysis of chromosome 8 from Bethesda C57BL/6J-
Plat/ mice (Table S2 and Fig. 2) showed all SNPs but
one to be C57BL/6J specific. The single 129-specific SNP
(rs3709624, Table S2, indicated by red asterisk in Fig. 2)
also genotyped as 129 specific in two C57BL/6J control
mice purchased from Jackson Laboratories that were
included in the analysis (‘Control’, columns L and M in
Table S2), and we currently have no explanation for this
finding.
We next set out to provide direct experimental evidence
that the differential expression of chromosome 8 genes in
brains of Melbourne and Michigan C57BL/6J-Plat/
mice was not a consequence of loss of tPA, but rather a
result of retention of a 129-derived chromosomal seg-
ment. For this purpose, we interbred the new Bethesda
C57BL/6J-Plat/ mice with Michigan C57BL/6J-Plat/
mice to generate littermate pairs of Bethesda C57BL/6J-
Plat/ and Michigan C57BL/6J-Plat/ mice. These
mice, both devoid of tPA, were then subjected to tran-
scriptomic profiling by RNAseq using quadruplicate anal-
ysis. A conspicuous clustering of genes differentially
expressed in Bethesda C57BL/6J-Plat/ mice and Michi-
gan C57BL/6J-Plat/ littermates around chromosome 8
was again observed, with seven of 19 differentially
expressed genes (37%) located on chromosome 8
(P < 0.05), clustering 19 Mbp upstream to 2.9 Mbp
downstream from Plat (P < 0.000001) (Fig. 1C and
Table 4). In sharp contrast, when the identical RNAseq
analysis was performed comparing brains from Bethesda
C57BL/6J-Plat/ mice with those from their wild-type
littermates, no over-representation of differentially
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Fig. 2. Congenic tPA-deficient mice contain large contiguous segments of 129-derived DNA. High-density single nucleotide polymorphism
(SNP) analysis of congenic ‘Michigan’ C57BL/6J-Plat/ mice (A), congenic ‘Melbourne’ C57BL/6J-Plat/ mice (B) and isogenic ‘Bethesda’
C57BL/6J-Plat/ mice (C). Positions of SNPs specific for strain 129 mice vs. C57BL/6J mice are indicated with red asterisks, and the positions
of SNPs specific for strain C57BL/6J mice vs. strain 129 mice are indicated with black circles.
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expressed genes on chromosome 8 was found, with only
two of 37 differentially expressed genes (5%) residing on
chromosome 8 (P = NS), located, respectively, 50 and
61 Mbp from Plat (Fig. 1D and Table 5) (P = NS).
Discussion
This current study provides evidence that tPA-deficient
mice highly backcrossed to C57BL/6J mice display differ-
ences in gene expression in the brain that are not related
to the absence of tPA, but rather to the way the Plat gene
was targeted. Two colonies of highly backcrossed C57BL/
6J-Plat/ mice, made by targeting Plat 129-derived ES
cells, showed the same anomalous clustering of differen-
tially expressed genes in the vicinity of Plat, when inde-
pendently analyzed by whole genome array analysis and
RNAseq. In the two analyses, 86 and 25% of all differen-
tially expressed genes were located within a segment of
chromosome 8 roughly 19 Mbp upstream to 8 Mbp
downstream of Plat. Considering the length of the mouse
genome of more than 2600 Mbp, less than 1.5% of differ-
entially expressed genes would be expected to be located
on this short segment of chromosome 8, which constitutes
just 1.03% of the mouse genome. Furthermore, an iso-
genic C57BL/6J-Plat/ mouse strain, generated in this
study by Zfn-mediated genome editing in C57BL/6J mice,
did not show this anomalous clustering of differentially
expressed genes. High-density SNP analysis showed that
both Melbourne and Michigan C57BL/6J-Plat/ mice
contained a surprisingly large contiguous 129-derived
chromosomal segment, and we provide direct experimen-
tal evidence that the presence of this chromosomal seg-
ment is responsible for the anomalous clustering of
differentially expressed genes in C57BL/6J-Plat/ mice.
Importantly, the 129-derived chromosomal segment
that co-segregates with the targeted Plat allele displayed a
number of differences in coding regions, when compared
with the corresponding chromosomal segment of C57BL/
6J mice, with at least four protein-coding genes poten-
tially being null in the 129 mice and wild-type in C57BL/
6J mice or vice versa, and eight additional genes display-
ing non-conservative amino acid substitutions. Notably,
some of these genes have reported roles in human brain
function: ARHGEF18 is involved in neurite retraction [30]
and was linked in a genome-wide association study to
sexual dysfunction in individuals treated for major
depression [31]. MCF2L participates in the formation and
stabilization of glutaminergic synapses of cortical neurons
[32], and SNPs in MCF2L and TUBGCP3 were identified
as predictive for successful smoking cessation [33].
Homozygosity for mutations in MCPH1 causes micro-
cephaly [34], whereas homozygous loss of ADAM3A is
associated with pediatric high-grade glioma and diffuse
intrinsic pontine gliomas [35].














loss Frame shift Missense
Arhgef18 3.40 19.30 T315M;S975P + +
Cd209a 3.74 18.96 After C64 R13G;T36P + +
Cd209e 3.85 18.85 W208Stop + +
Cd209b 3.92 18.78 R247Stop C42S; I259V
A175V; T369A; V389M; E428G;
V439I;
R524Q; P558L; T559A; S620P;
P690S;
+ +
BC068157 4.21 18.49 F716L;P779T;S950A
S82P; W86R; H116Y; E120K;
P154S;
+ +
Ccl25 4.34 18.36 After P98 M169I + +
Tubgcp3 12.64 10.06 G190S + +
Mcf2l 12.95 9.75 Stop1102L + +
Myom2 15.10 7.60 R123Q;M131L;S234P;L977I;
S1311N
A300V; A303V; S469L; C580F;
T615A;
+ +
Mcphl 18.60 4.10 T615K + +
Defb34 19.12 3.58 After D25 + +
Defb46 19.24 3.46 C32Stop C21F + +
ENSMUSG00000097230 19.79 2.91 + +
AY761185 20.94 1.76 + +
Plat 22.70 0 N/A N/A
ADAM3 24.70 2.00 Stop823S G741D +
N/A, not applicable.
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Fig. 3. Generation of isogenic C57BL/6J-Plat/ and FVB/NJ-Plat/ mice. (A) De novo generation of Plat null allele. Schematic structure of
the proximal part of the mouse Plat gene (top), and the sequence of the signal peptide-encoding exon 2 (upper case letters) and flanking intron
sequences (lower case letters) (bottom). The Zfn binding sites are in bold letters, with the Zfn cleavage site in red. The 11 bp deleted in the
C57BL/6J and FVB/NJ strains carried forward for analysis are underlined. This deletion introduces a frame shift resulting in the production of
a mRNA encoding amino acid 1-17 of tPA fused to a 19 amino acid nonsense peptide. (B) Plasminogen-casein zymography. Lanes 1–4: puri-
fied human tPA. Lanes 5–8: protein extracts from brains of a litter of FVB/NJ mice containing two wild-type (lanes 5 and 8) and 2 Plat/ lit-
termates (lanes 6 and 7). (C) tPA Western blot. Lane 1: purified human tPA. Lanes 2–5: protein extracts from brains of a litter of mice
containing two wild-type (lanes 2 and 5) and two Plat/ littermates (lanes 3 and 4). (D) Active tPA (middle column) and total tPA (right col-
umn) protein extracts from brains of a litter of mice containing two wild-type (top and bottom row) and two Plat/ littermates (middle rows).
Table 4 Chromosomal location or genes differentially expressed in
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It should be noted that the 129-derived co-segregating
chromosomal segments identified in the congenic C57BL/
6J-Plat/ mouse strains have the potential to confound
data interpretation irrespective of whether the wild-type
mice used as controls are littermate-derived or age- and
sex-matched C57BL/6J mice. Our study, thus, highlights
the importance of reconstitution experiments in non-iso-
genic mice, where a wild-type phenotype can be restored
via the introduction of exogenous tPA into tPA-deficient
mice [11], or where tPA-overexpressing mice exhibit an
opposite phenotype to that of tPA-deficient mice [36].
Similarly, with regards to plasmin-dependent functions of
tPA, one can eliminate the confounding effects of co-
inherited passenger mutations when tPA-deficient and
plasminogen-deficient mice exhibit similar phenotypes
[37]. It is important to stress, however, that the present
study provides no evidence, directly or indirectly, that
any of the published phenotypes in tPA-deficient mice are
caused by 129-derived passenger mutations co-inherited
with the targeted Plat allele. Nonetheless, it is also clear
from the data presented in the current study that caution
must be exerted when interpreting phenotypes observed in
C57BL/6J-Plat/ mice. Related to this, it is interesting
to note that this region of chromosome 8, which is syn-
tenic with human chromosome 8, has been suggested to
be a potential hub for genes associated with neuropsychi-
atric disorders and with cancer [38]. Undoubtedly, the
C57BL/6J-Plat/ and FVB/NJ-Plat/ mice generated
here should provide two novel mouse strains for the
research community to further explore tPA function;
strains which are free of co-inherited passenger mutations
that are inevitable when using 129-derived ES cells. Nev-
ertheless, the Zfn technology used to generate the two
mouse strains is relatively new, and the degree to which
‘off-targeting’ of the germ line occurs has not been fully
investigated [39,40]. Potential off-target mutations in the
two novel mouse strains, however, would only constitute
a potential long-term problem if located in proximity to
Plat.
It should also be stressed that in conditionally-targeted
strains, the potential of passenger mutations to confound
data interpretation can largely be eliminated by the use of
appropriate littermate controls, including Cre-negative lit-
termates that carry two conditionally targeted alleles and,
therefore, are expected to carry the same set of passenger
mutations near the gene of interest [2].
The plasminogen activation system was among the first
proteolytic systems to be analyzed by gene targeting in
mice. Consequently, targeting of genes encoding most
components of the system was carried out using 129-
derived ES cells. This includes, besides Plat, Plau[29],
Plaur[41,42], Plg[43,44], Serpine1[45], SerpinF2[46] and
Annat2[47]. In light of the speed, efficiency and low cost
of current genome editing technologies, the regeneration
of isogenic strains carrying null mutations in these genes
should be considered.
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